Christian Thiede

1995–2025 年に発表

161
論文数
26,355
被引用数
84
h 指数
156
i10 指数

被引用数

Christian Thiede の年別被引用数1991 年: 被引用 1 件1996 年: 被引用 7 件1997 年: 被引用 25 件1998 年: 被引用 16 件1999 年: 被引用 28 件2000 年: 被引用 48 件2001 年: 被引用 61 件2002 年: 被引用 76 件2003 年: 被引用 97 件2004 年: 被引用 101 件2005 年: 被引用 154 件2006 年: 被引用 138 件2007 年: 被引用 137 件2008 年: 被引用 121 件2009 年: 被引用 108 件2010 年: 被引用 131 件2011 年: 被引用 139 件2012 年: 被引用 133 件2013 年: 被引用 117 件2014 年: 被引用 163 件2015 年: 被引用 141 件2016 年: 被引用 151 件2017 年: 被引用 163 件2018 年: 被引用 169 件2019 年: 被引用 836 件2020 年: 被引用 928 件2021 年: 被引用 938 件2022 年: 被引用 811 件2023 年: 被引用 792 件2024 年: 被引用 969 件2025 年: 被引用 422 件2026 年: 被引用 13 件1992〜1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,352 件、この内訳の 25.4%ドイツ: 引用元論文 1,004 件、この内訳の 10.8%中国: 引用元論文 738 件、この内訳の 8%イギリス: 引用元論文 552 件、この内訳の 5.9%イタリア: 引用元論文 544 件、この内訳の 5.9%フランス: 引用元論文 470 件、この内訳の 5.1%オランダ: 引用元論文 320 件、この内訳の 3.4%スペイン: 引用元論文 279 件、この内訳の 3%日本: 引用元論文 279 件、この内訳の 3%カナダ: 引用元論文 265 件、この内訳の 2.9%スイス: 引用元論文 219 件、この内訳の 2.4%オーストラリア: 引用元論文 195 件、この内訳の 2.1%
0%25.4%その他 22.1%

分野

  • Medicine72%
  • Biochemistry, Genetics and Molecular Biology21.4%
  • Immunology and Microbiology3.2%
  • Computer Science1.5%
  • Chemistry0.4%
  • Engineering0.2%
  • その他1.3%

トピック

  • Acute Myeloid Leukemia Research18%
  • Hematopoietic Stem Cell Transplantation4.9%
  • Acute Lymphoblastic Leukemia research4.4%
  • Chronic Myeloid Leukemia Treatments4.2%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment3.6%
  • Histone Deacetylase Inhibitors Research3.1%
  • その他61.8%

共著者

全論文

検索で開く
  1. Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 被引用: 2,198

  2. 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Farhad Ravandi, Christophe Roumier, Marion Subklewe, Felicitas Thol, Arjan A. van de Loosdrecht, Bert A. van der Reijden, Adriano Venditti, Agnieszka Wierzbowska, Peter J.M. Valk, Brent L. Wood, Roland B. Walter, Christian Thiede, Konstanze Döhner, Gail J. Roboz, Jacqueline Cloos - Blood 2021 被引用: 718

  3. Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hartmut Link, Maria Grazia Kropp, Alessandro Rambaldi, Giorgio La Nasa, Mario Luppi, Fabio Ciceri, Olimpia Finizio, Adriano Venditti, Francesco Fabbiano, Konstanze Döhner, Michaela Sauer, Arnold Ganser, Sergio Amadori, Franco Mandelli, Hartmut Döhner, Gerhard Ehninger, Richard F. Schlenk, Uwe Platzbecker - New England Journal of Medicine 2013 被引用: 1,606

  4. Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Blood 2018 被引用: 1,029

  5. Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation (SORMAIN)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christian Brandts, Susanne Harnisch, Michael Wittenberg, Heinz‐Gert Hoeffkes, Susanne Rospleszcz, Alexander Burchardt, Andreas Neubauer, Markus Brugger, Konstantin Strauch, Carmen Schade‐Brittinger, Stephan Metzelder - Journal of Clinical Oncology 2020 被引用: 551

  6. BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anthony D. Ho, Jeroen Krijgsveld, Bernhard Radlwimmer, Andreas Trumpp - Nature 2017 被引用: 353

  7. The proteogenomic subtypes of acute myeloid leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel Hübschmann, Lars Kaderali, Jürgen Cox, Bernhard Brüne, Christoph Röllig, Christian Thiede, Björn Steffen, Martin Bornhäuser, Andreas Trumpp, Henning Urlaub, Kimberly Stegmaier, Hubert Serve, Matthias Mann, Thomas Oellerich - Cancer Cell 2022 被引用: 147

  8. Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia

    著者: , , , , , , , , , , , - Blood Cancer Journal 2014 被引用: 352

  9. Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christian Thiede - The Lancet Oncology 2018 被引用: 354

  10. Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears

    著者: , , , , , , , , , , , , , - Leukemia 2021 被引用: 119

  11. CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katja Sockel, Malte von Bonin, Carsten Müller‐Tidow, Uwe Platzbecker, Wolfgang E. Berdel, Hubert Serve, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig, Christian Thiede, for the Study Alliance Leukemia (SAL) - Blood 2021 被引用: 164

  12. Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears

    著者: , , , , , , , , , , , , , , , , - BMC Cancer 2022 被引用: 76

  13. A Dynamic rRNA Ribomethylome Drives Stemness in Acute Myeloid Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2022 被引用: 70

  14. Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guido Kobbe, Markus Wiesneth, Michael Koldehoff, Gèrard Socié, Nicolaus Kröger, Lars Bullinger, Christian Thiede, Frédérik Damm - Journal of Clinical Oncology 2018 被引用: 220

  15. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

    著者: , , , , , , , , , , , - Blood 2002 被引用: 1,729

  16. Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Heinz Dürk, Jana Hase, Ina‐Maria Klut, Thomas Illmer, Martin Bornhäuser, Markus Schaich, Stefani Parmentier, Martin Görner, Christian Thiede, Malte von Bonin, Johannes Schetelig, Michael Krämer, Wolfgang E. Berdel, Gerhard Ehninger - The Lancet Oncology 2015 被引用: 400

  17. Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sergio Amadori, Insa Gathmann, Axel Benner, Céline Pallaud, Richard M. Stone, Hartmut Döhner, Clara D. Bloomfield - Blood 2019 被引用: 193

  18. Antigen presentation safeguards the integrity of the hematopoietic stem cell pool

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefan B. Eichmüller, Wolf‐Karsten Hofmann, Daniel Nowak, Daniel Hübschmann, Michael Hundemer, Christian Thiede, Lars Bullinger, Carsten Müller‐Tidow, Scott A. Armstrong, Andreas Trumpp, Vijay K. Kuchroo, Simon Haas - Cell stem cell 2022 被引用: 85

  19. Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chiara Frairia, Enrico Maria Pogliani, Claudio Fozza, Alfonso Maria D’Arco, Nicola Di Renzo, Agostino Cortelezzi, Francesco Fabbiano, Konstanze Döhner, Arnold Ganser, Hartmut Döhner, Sergio Amadori, Franco Mandelli, Gerhard Ehninger, Richard F. Schlenk, Francesco Lo‐Coco - Journal of Clinical Oncology 2016 被引用: 392

  20. Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2016 被引用: 267

  21. Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Cancer 2021 被引用: 76

  22. TERT Promoter Mutation Detection in Cell-Free Tumor-Derived DNA in Patients with IDH Wild-Type Glioblastomas: A Pilot Prospective Study

    著者: , , , , , , , , , , , , , , - Clinical Cancer Research 2018 被引用: 109

  23. Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatment

    著者: , , , , , , , , , , , , , , - Blood Advances 2022 被引用: 56

  24. Radiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups

    著者: , , , , , , , , , , , - Journal of Neuro-Oncology 2018 被引用: 110